BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2251526)

  • 1. Chancroid: results from an outbreak in Houston, Texas.
    Jones C; Rosen T; Clarridge J; Collins S
    South Med J; 1990 Dec; 83(12):1384-9. PubMed ID: 2251526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chancroid and granuloma inguinale.
    Ronald AR; Plummer FA
    Clin Lab Med; 1989 Sep; 9(3):535-43. PubMed ID: 2676322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus ducreyi infection in south Florida: a rare disease on the rise?
    Becker TM; DeWitt W; Van Dusen G
    South Med J; 1987 Feb; 80(2):182-4. PubMed ID: 3492766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose ceftriaxone for chancroid.
    Bowmer MI; Nsanze H; D'Costa LJ; Dylewski J; Fransen L; Piot P; Ronald AR
    Antimicrob Agents Chemother; 1987 Jan; 31(1):67-9. PubMed ID: 3566241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
    Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
    Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of spectinomycin and erythromycin in the treatment of chancroid.
    Ballard RC; da L'Exposto F; Dangor Y; Fehler HG; Miller SD; Koornhof HJ
    J Antimicrob Chemother; 1990 Sep; 26(3):429-34. PubMed ID: 2146242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chancroid and Haemophilus ducreyi: an update.
    Trees DL; Morse SA
    Clin Microbiol Rev; 1995 Jul; 8(3):357-75. PubMed ID: 7553570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the RapID-ANA system and sodium polyanetholesulfonate disk susceptibility testing in identifying Haemophilus ducreyi.
    Shawar R; Sepulveda J; Clarridge JE
    J Clin Microbiol; 1990 Jan; 28(1):108-11. PubMed ID: 2153697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid control of a chancroid outbreak: implications for Canada.
    Jessamine PG; Brunham RC
    CMAJ; 1990 May; 142(10):1081-5. PubMed ID: 2337844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
    Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
    J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
    Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and therapy of ulcus molle today. Case report and review of the literature].
    Korting HC; Abeck D; Neubert U; Johnson AP; Fröschl M; Braun-Falco O
    Hautarzt; 1989 Jul; 40(7):418-22. PubMed ID: 2668230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chancroid in Dallas: new lessons from an old disease.
    Farris JR; Hutcheson D; Cartwright G; Glover JH
    Tex Med; 1991 May; 87(5):78-81. PubMed ID: 1882362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures.
    Blackmore CA; Limpakarnjanarat K; Rigau-Pérez JG; Albritton WL; Greenwood JR
    J Infect Dis; 1985 May; 151(5):840-4. PubMed ID: 2985711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium.
    Hafiz S; Kinghorn GR; McEntegart MG
    Br J Vener Dis; 1981 Dec; 57(6):382-6. PubMed ID: 6976815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen?
    Lewis DA
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):687-96. PubMed ID: 24597521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of azithromycin and ceftriaxone for the treatment of chancroid.
    Martin DH; Sargent SJ; Wendel GD; McCormack WM; Spier NA; Johnson RB
    Clin Infect Dis; 1995 Aug; 21(2):409-14. PubMed ID: 8562752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America.
    Hammond GW; Slutchuk M; Scatliff J; Sherman E; Wilt JC; Ronald AR
    Rev Infect Dis; 1980; 2(6):867-79. PubMed ID: 6971469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudogranuloma inguinale caused by haemophilus ducreyi.
    Kraus SJ; Werman BS; Biddle JW; Sottnek FO; Ewing EP
    Arch Dermatol; 1982 Jul; 118(7):494-7. PubMed ID: 7046641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.